Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol in Bipolar Depression
DRKS00012657Phase 2Not yet recruiting
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in bipolar disorder (BD) comparing Cannabidiol add-on with Placebo add-on (2 arms). Planned start Jul 2017; status: not yet recruiting.
02
Drugs
cannabidiol
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on DRKS00012657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00012657.